Loading...
No free rides: management of toxicities of novel immunotherapies in ALL, including financial
Therapeutic options for acute lymphoblastic leukemia, especially in the relapsed/refractory setting, have expanded significantly in recent times. However, this comes at the cost of toxicities: medical as well as financial. We highlight some of the unique toxicities associated with the novel agents t...
Saved in:
| Published in: | Blood Adv |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Hematology
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6258912/ https://ncbi.nlm.nih.gov/pubmed/30482769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018020198 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|